Atlas FDA

ESSURE CONTRACEPTIVE TUBAL OCCLUSION DEVICE AND DELIVERY SYSTEM

FDA premarket approval P020014/S019 · decided 2008-10-08

Approval details

PMA number
P020014
Supplement
S019
Supplement type
Normal 180 Day Track No User Fee
Supplement reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
ESSURE CONTRACEPTIVE TUBAL OCCLUSION DEVICE AND DELIVERY SYSTEM
Generic name
Transcervical contraceptive tubal occlusion device
Applicant
Bayer Pharma AG
Date received
2008-06-30
Decision date
2008-10-08
Days to decision
100 days
Decision code
APPR
Product code
HHS
Advisory committee
Obstetrics/Gynecology
Expedited review
No
Location
Berlin
Statement
APPROVAL FOR A CONTRACT STERILIZATION SITE LOCATED AT STERIGENICS US, INC., SANTA TERESA, NEW MEXICO.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.